NM_001031726.3(C19orf12):c.199dup AND Hereditary spastic paraplegia 43

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Apr 20, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV002237737.11

Allele description [Variation Report for NM_001031726.3(C19orf12):c.199dup]

NM_001031726.3(C19orf12):c.199dup

Gene:
C19orf12:chromosome 19 open reading frame 12 [Gene - OMIM - HGNC]
Variant type:
Duplication
Cytogenetic location:
19q12
Genomic location:
Preferred name:
NM_001031726.3(C19orf12):c.199dup
HGVS:
  • NC_000019.10:g.29702978dup
  • NG_031970.2:g.17818dup
  • NC_000019.9:g.30193878_30193879insC
  • NC_000019.9:g.30193885dup
  • NM_001031726.3:c.199dup
Links:
dbSNP: rs398122409
NCBI 1000 Genomes Browser:
rs398122409

Condition(s)

Name:
Hereditary spastic paraplegia 43
Synonyms:
Spastic paraplegia 43, autosomal recessive
Identifiers:
MONDO: MONDO:0014024; MedGen: C2680446; Orphanet: 320370; OMIM: 615043

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV002510900Labcorp Genetics (formerly Invitae), Labcorp
criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))
Uncertain significance
(Apr 20, 2023)
germlineclinical testing

PubMed (3)
[See all records that cite these PMIDs]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

PANK2 and C19orf12 mutations are common causes of neurodegeneration with brain iron accumulation.

Dezfouli MA, Alavi A, Rohani M, Rezvani M, Nekuie T, Klotzle B, Tonekaboni SH, Shahidi GA, Elahi E.

Mov Disord. 2013 Feb;28(2):228-32. doi: 10.1002/mds.25271. Epub 2012 Nov 19.

PubMed [citation]
PMID:
23166001

Mitochondrial Membrane Protein-Associated Neurodegeneration: A Case Series of Six Children.

Incecik F, Herguner OM, Bisgin A.

Ann Indian Acad Neurol. 2020 Nov-Dec;23(6):802-804. doi: 10.4103/aian.AIAN_268_19. Epub 2019 Sep 17.

PubMed [citation]
PMID:
33688131
PMCID:
PMC7900730
See all PubMed Citations (3)

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV002510900.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (3)

Description

In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies and prediction algorithms are not available or were not evaluated, and the functional significance of this variant is currently unknown. ClinVar contains an entry for this variant (Variation ID: 1682831). This variant is also known as c.191insG (p.Ala67GlyfsX14) and c.166_167insG (p.Ala56Glys*16). This premature translational stop signal has been observed in individuals with autosomal recessive mitochondrial membrane protein-associated neurodegeneration and/or autosomal recessive neurodegeneration with brain iron accumulation (PMID: 23166001, 33688131). The frequency data for this variant in the population databases is considered unreliable, as metrics indicate poor data quality at this position in the gnomAD database. This sequence change creates a premature translational stop signal (p.Ala67Glyfs*16) in the C19orf12 gene. While this is not anticipated to result in nonsense mediated decay, it is expected to disrupt the last 86 amino acid(s) of the C19orf12 protein.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024